ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42883798

p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability.

Grassi I and 10 others. Int J Mol Sci, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability. Papers, record 42883798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42883798

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability.
Journal
Int J Mol Sci
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-20

Source PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grassi IIlariahttps://orcid.org/0009-0001-7940-4977
2Di Nicola EElisabettahttps://orcid.org/0009-0007-5880-9514
3Candela EErica
4Cavalcanti EElisabettahttps://orcid.org/0000-0003-2952-0053
5Valentini AAnnamariahttps://orcid.org/0000-0002-6798-808X
6Vincenti LLeonardo
7Santoiemma CCarlahttps://orcid.org/0009-0005-7442-1996
8Grossi VValentinahttps://orcid.org/0000-0003-3843-1618
9Lepore Signorile MMartinahttps://orcid.org/0000-0002-3794-7834
10Simone CCristiano

1 to 10 of 11Source PubMed

See all 11 authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Pancreatic DuctalMajor topic
Pancreatic NeoplasmsMajor topic
Mitogen-Activated Protein Kinase 14Major topic
Humans
Cell Line, Tumor
Disease Progression
Signal Transduction
Gene Expression Regulation, Neoplastic
Apoptosis

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Ricerca Corrente 2024-2026 to C.SItalian Ministry of HealthPubMed
Ricerca Corrente 2023-2025 to V.GItalian Ministry of HealthPubMed
Ricerca Corrente 2024-2026 to R.A.Italian Ministry of HealthPubMed
Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (PNRR-POC2023-12378288, CUP: G23C24000900006) to V.G.European Union-Next Generation EU-NRRP M6C2PubMed
(ID31217-2024).AIRC Fellowship for Italy to E.D.N.PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137,059,070Pancreatic cancer: Advances and challenges.Cell2023https://conductscience.org/library/papers/37059070PubMed
230,949,842Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues.Surg Today2019https://conductscience.org/library/papers/30949842PubMed
340,182,139Pancreatic Cancer: Pathogenesis and Clinical Studies.MedComm (2020)2025https://conductscience.org/library/papers/40182139PubMed
436,051,096Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma.World J Gastrointest Oncol2022https://conductscience.org/library/papers/36051096PubMed
521,499,212Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.Pancreas2011https://conductscience.org/library/papers/21499212PubMed
641,156,387Bioengineering 3D Pancreatic Cancer Models with Fibrotic Stroma for In Vitro Cancer Modeling.Micromachines (Basel)2025https://conductscience.org/library/papers/41156387PubMed
732,133,645Colorectal cancer statistics, 2020.CA Cancer J Clin2020https://conductscience.org/library/papers/32133645PubMed
826,361,402Early detection of pancreatic cancer.Chin J Cancer Res2015https://conductscience.org/library/papers/26361402PubMed
940,662,372Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception.J Clin Invest2025https://conductscience.org/library/papers/40662372PubMed
1031,433,515The 2019 WHO classification of tumours of the digestive system.Histopathology2020https://conductscience.org/library/papers/31433515PubMed

1 to 10 of 45

See all 45 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42883798

GET https://conductscience.org/api/papers/v1/42883798/references?page=2

API referenceFor AI assistants